Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
REUTERS SHOWCASE
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Westpac says rupee likely to enjoy positive start to 2013
Reuters Market Eye - Westpac says the rupee could enjoy a positive start to 2013 as the recent rebound in factory output, PMI data, along with equity market resilience is pointing towards a better growth environment for India through first half of 2013.
"Combined with a likely RBI rate cut in the early part of Q1 and we suspect the market will feel more comfortable in a rebound in growth," says Westpac in a note.
Any rate cut will encourage further capital inflows, and will provide positive back drop for USD/INR view of 53.8 for end March, the note says.
January has been a historically much better month for Asian currencies compared with May, June and August, says Westpac. In fact, historical data shows INR has the best mean return for January (0.83 percent), followed by THB and IDR.
The RBI is unlikely to curb any INR strength unlike other Asian peers. Any jump in USD/INR between now and end of the year can be viewed as an opportunity to sell, it says.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters